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Background: Naturally occurring flavonoids have been reported to possess various pharmacological properties. The
aim of this study was to evaluate the antimicrobial and antioxidant activities of the MeOH extract and flavonoids
from the leaves of Oncoba spinosa, a plant used for the treatment of syphilis, wounds and sexual impotence.
Methods: The plant extract was prepared by maceration in methanol and sequentially fractionated by column
chromatography. The structures of isolated compounds were elucidated on the basis of spectral studies and
comparison with published data. The MeOH extract and its isolated compounds were evaluated for their
antibacterial and antifungal activities by broth microdilution method. The 1,1-diphenyl-2-picrylhydrazyl (DPPH) and
trolox equivalent antioxidant capacity (TEAC) assays were used to detect the antioxidant activity. The samples were
tested spectrophotometrically for their hemolytic properties against human red blood cells.
Results: The fractionation of the MeOH extract afforded five known flavonoids including kaempferol (1), quercetin
(2), apigenin-7-O-β-D-glucuronopyranoside (3), quercetin 3-O-β-D-galactopyranoside (4) and quercetin 3-O-α-L-
rhamnopyranosyl (1→ 6) β-D-glucopyranoside (5). The MeOH extract displayed weak to moderate antimicrobial
activities (MIC = 256–2048 μg/ml). Quercetin 3-O-α-L-rhamnopyranosyl (1→ 6) β-D-glucopyranoside (5) and
quercetin (2) were respectively the most active compounds against bacteria (MIC = 8–64 μg/ml) and fungi (MIC =
64 – 128 μg/ml). These tested samples also showed high radical-scavenging activities (EC50 = 5.08 – 70.56 μg/ml)
and gallic acid equivalent antioxidant capacities (TEAC = 53.76 – 89.86 μg/ml) when compared with vitamin C
(EC50 = 4.72 μg/ml). The MeOH extract and compounds 2–5 were non-toxic to human red blood cells indicating
their high selectivity to be used as antimicrobial and antioxidant drugs.
Conclusion: The MeOH extract of O. spinosa as well as compounds 2 – 5 could be a potential source of natural
antimicrobial and antioxidant products.
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Infectious diseases are among the main cause of morbid-
ity and mortality worldwide, with HIV, tuberculosis and
malaria being the most involved. Despite the progress
made in the understanding of microorganisms and their
control in industrialized nations, incidents due to drug
resistant microorganisms and the emergence of hitherto
unknown disease-causing microbes, pose enormous pub-
lic health concerns [1]. Furthermore, the development of* Correspondence: jtamokou@yahoo.fr
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sistance [2]. Consequently, this has created a new
renewed interest in the search for new drugs in order to
combat resistance. The need for new, effective and af-
fordable drugs to treat microbial diseases in the develop-
ing world is one of the major issues facing global health
today. Plants have been used as a source of new medi-
cinal compounds throughout history and continue to
serve as the basis for many of the pharmaceuticals used
today [3]. In recent decades, many studies have been
carried out on different plant species to discover com-
pounds of possible interest for medicinal application
against oxidative stress, fungal and bacterial infections.l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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logical and phytochemical properties of different species
of the family Flacourtiaceae [4-6].
Oncoba spinosa Forssk. belonging to the family Fla-
courtiaceae (Salicaceae sensu lato) is a small tree of about
13 m high which grows under conditions of higher rain-
fall, of deciduous, secondary and fringing forest from
Senegal to West Cameroon, and widely distributed in
tropical Africa and Arabia [7]. The plant is traditionally
reputed for its medicinal potential particularly in south-
west of Nigeria for the treatment of diabetes and cancer
[6]. In many African countries, the leaves and roots are
used for urethral discharges, infertility [8], epilepsy [9],
dysentery and bladder conditions [10]. The α-glucosidase
inhibitory, radical scavenging and cytotoxicity activities
of the aqueous and chloroform extracts of the leaves of
O. spinosa were reported [6]. The methanol extract of the
fruits of this plant collected in Yemen demonstrated anti-
microbial, anticancer and antioxidant activities [5]. Previ-
ous phytochemical studies on the genus Oncoba afforded
three tetracyclic triterpenes from the species O. mannii
[4]. Phytochemical screening of O. spinosa leaves re-
vealed the presence of anthraquinones, alkaloids, phe-
nols, sterols, tannins, carbohydrates and flavonoids [6].
In our continuous effort to search for novel antimicro-
bial/antioxidant agents from Cameroonian medicinal
plants used traditionally to treat human microbial infec-
tions and oxidative related diseases [11-14], we investi-
gated phytochemically and biologically the methanol
extract of the leaves of O. spinosa and isolated five
known compounds. They included kaempferol (1) [15],
quercetin (2) [16], apigenin-7-O-β-D-glucuronopyrano-
side (3) [17,18], quercetin 3-O-β-D-galactopyranoside
(4) [16] and quercetin 3-O-α-L-rhamnopyranosyl (1→
6) β-D-glucopyranoside (5) [19]. The in vitro antibacter-
ial, antifungal and antioxidant activities of the MeOH
extract and compounds 2–5 were evaluated.Methods
Experimental
Melting points were recorded with a Reichert micro-
scope and are uncorrected. 1H NMR (500 MHz) and 13C
NMR (125 MHz) were recorded at room temperature in
CD3OD or (CD3)2SO, on a Bruker Avance DRX-500
spectrometer. Chemical shifts (δ) are reported in parts
per million (ppm) with the solvent signals as reference
relative to TMS (δ = 0) as internal standard, while the
coupling constants (J values) are given in Hertz (Hz).
COSY, ROESY, TOCSY, HSQC and HMBC experiments
were recorded with gradient enhancements using sine
shape gradient pulses. The IR spectra were recorded
with a Shimadzu FT-IR-8400S spectrophotometer. ESI-
MS experiments were performed using a MicromassQ-TOF micro instrument (Manchester, UK) with an
electrospray source. Column chromatography was run
on Merck silica gel 60 (70–230 mesh) and gel perme-
ation on Sephadex LH-20 while TLC was carried out on
silica gel GF254 pre-coated plates with detection accom-
plished by spraying with 50% H2SO4 followed by heating
at 100°C, or by visualizing with an UV lamp at 254 and
365 nm.
Plant material
The leaves of O. spinosa Forssk. were collected at Dschang,
West Region, Cameroon, in May 2007. Authentication was
done at the Cameroon National Herbarium, Yaoundé,
where the voucher specimen (No. 21975 HNC) is
deposited.
Extraction and isolation
The air-dried and powdered leaves of O. spinosa (2 kg)
were extracted by percolation in methanol for 3 days at
room temperature. Evaporation of solvent under reduced
pressure yielded 40 g of extract. Part of the MeOH ex-
tract (35 g) was subjected to column chromatography
(silica gel 60, 70–230 mesh) and eluted with hexane
followed by hexane-EtOAc gradient. Sixty fractions of
200 ml each were collected and combined on the basis
of TLC analysis to afford four major fractions: A (9 g;
hexane-EtOAc 100:0 and 9:1), B (8.5 g, hexane-EtOAc
4:1 and 7:3), C (11 g, hexane-EtOAc 1:1 and 0:100) and
D (6.7 g, EtOAc-MeOH 19:1 and 9:1). Fraction A,
mainly oil, was not further investigated in this work.
Fraction B was further purified on silica gel column
chromatography eluted with hexane-EtOAc 17:3, 4:1 and
3:1, respectively, to afford 30 sub-fractions (B1 and B2).
Sub-fraction B2 (17–30) was purified through Sephadex
LH-20 column chromatography eluted with CH2Cl2-
MeOH 1:1 to yield kaempferol (1) (2.5 mg), quercetin
(2) (5 mg) and apigenin-7-O-β-D-glucuronopyranoside
(3) (11 mg). Silica gel column chromatography of frac-
tion C, eluted with EtOAc-MeOH-H2O 9:0.5:0.5 yielded
apigenin-7-O-β-D-glucuronopyranoside (3) (25 mg) and
quercetin 3-O-β-D-galactopyranoside (4) (33 mg). Frac-
tion D was purified through Sephadex LH-20 gel perme-
ation eluted with MeOH to give 25 sub-fractions (10 ml
each). Re-crystallization of these sub-fractions yielded quer-
cetin 3-O-β-D-galactopyranoside (4) (6 mg), quercetin 3-
O-α-L-rhamnopyranosyl (1→ 6) β-D-glucopyranoside (5)
(24.5 mg) and complex mixtures.
Kaempferol (1): yellow crystals from hexane-EtOAc;
m.p. 275–277°C; C15H10O6.
Quercetin (2): yellow needles from hexane-EtOAc;
m.p. > 300°C; C15H10O7.
Apigenin-7-O-β-D-glucuronopyranoside (3): yellow
powder from EtOAc; m.p. > 300°C; C21H18O11.
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from EtOAc-MeOH; m.p. 230–232°C; C21H20O12.
Quercetin 3-O-α-L-rhamnopyranosyl (1→ 6) β-D-
glucopyranoside (5): yellow powder from EtOAc-
MeOH, m.p. 213–216°C; C27H30O16.
Antimicrobial assay
Bacterial and fungal strains
The studied microorganisms were both reference (from
the American Type Culture Collection) and clinical
(from Pasteur Institute Paris, France) strains of Entero-
bacter aerogenes, Escherichia coli, Klebsiella pneumoniae,
Candida albicans, and Cryptococcus neoformans. Also,
included were two clinical isolates of Candida parapsilo-
sis and Staphylococcus aureus collected from Pasteur
Centre (Yaoundé-Cameroon). The bacterial and fungal
species were grown at 37°C and maintained on nutrient
agar (NA, Conda, Madrid, Spain) and Sabouraud Dex-
trose Agar (SDA, Conda) slants respectively.
Preparation of microbial inoculum
The inocula of yeasts and bacteria were prepared from
overnight cultures by picking numerous colonies and
suspending them in sterile saline (NaCl) solution (0.90%).
Absorbance was read at 530 nm for yeasts or at 600 nm
for bacteria and adjusted with the saline solution to
match that of a 0.50 McFarland standard solution. From
the prepared microbial solutions, other dilutions with sa-
line solution were prepared to give a final concentration
of 106 yeast cells/ml and 106 CFU/ml for bacteria [14,20].
Antimicrobial assay
The antimicrobial activity was investigated by determin-
ing the minimum inhibitory concentrations (MICs),
minimum bactericidal concentrations (MBCs) and mini-
mum fungicidal concentrations (MFCs).
MICs were determined by broth micro dilution [12,21].
Stock solutions of the tested samples were prepared in
10% v/v aqueous dimethylsulfoxide (DMSO) solution
(Fisher chemicals, Strasbourg, France) at concentration
of 4096 μg/ml. This was two-fold serially diluted in
Mueller-Hinton Broth (MHB) for bacteria and Sabouraud
Dextrose Broth (SDB) for fungi to obtain a concentration
range of 2048 to 0.25 μg/ml. For every experiment, a ster-
ility check (10% aqueous DMSO and medium), negative
control (10% aqueous DMSO, medium and inoculum)
and positive control (10% aqueous DMSO, medium, in-
oculum and water-soluble antibiotics) were included.
One hundred microliters of each concentration was in-
troduced into a well (96-wells microplate) containing
90 μl of SDB or MHB and 10 μl of inoculum was added
to obtain a final concentration range of 4096 to 0.125 μg/
ml. The plates were covered with a sterile lid, and incu-
bated on the shaker at 37°C for 24 h (bacteria) and 48 h(yeasts). MICs were assessed visually after the corre-
sponding incubation period and were taken as the lowest
sample concentration at which there was no growth or
virtually no growth. The assay was repeated thrice.
For the minimum microbicidal concentration (MMC)
determination, 10 μl aliquots from each well that
showed no growth of microorganism were plated on
Mueller-Hinton Agar or Sabouraud Dextrose Agar and
incubated at 37°C for 24 h (bacteria) and 48 h (yeasts).
The lowest concentration that yielded no growth after
the sub-culturing was taken as the MBCs or MFCs.
Chloramphenicol (Sigma-Aldrich, Steinheim, Germany)
for bacteria and nystatin (Sigma-Aldrich, Steinheim,
Germany) for yeasts were used as positive controls.
Antioxidant assay
DPPH free radical scavenging assay
The free radical scavenging activity of the MeOH extract
as well as some of its isolated compounds was evaluated
according to described methods [22,23] with slight modi-
fications. Briefly, the test samples, prior dissolved in
DMSO (SIGMA) beforehand, were mixed with a 20 mg/l
2,2-diphenyl-1-picryl-hydrazyl (DPPH) methanol solu-
tion, to give final concentrations of 10, 50, 100, 500 and
1000 μg/ml. After 30 min at room temperature, the ab-
sorbance values were measured at 517 nm and converted
into percentage of antioxidant activity. L-ascorbic acid
was used as a standard control. The percentage of deco-
louration of DPPH (%) was calculated as follows:
% decolouration of DPPH ¼ Absorbance of control − Absorbance of test sampleð Þ  100Þ
Absorbance of control
The percentage of decolouration of DPPH (%) was
plotted against the test sample. Also, the percentage of
decolouration of DPPH was converted in probits. The
probit values were plotted against the logarithmic values
of concentrations of the test samples and a linear regres-
sion curve was established in order to calculate the EC50
(μg/ml), which is the amount of sample necessary to
decrease by 50% the absorbance of DPPH [11]. All the
analyses were carried out in triplicate.
Trolox equivalent antioxidant capacity (TEAC) assay.
The TEAC test was done as previously described [24] with
slight modifications. In a quartz cuvette, to 950 μl acetate
buffer (pH = 5.0, 100 mM), the following were added:
20 μl laccase (1 mM stock solution), 20 μl test sample,
10 μl ABTS (2,2′-azinobis(3-ethylbenzothiazoline-6-sul-
fonic acid)) (74 mM stock solution). The laccase were
purified from Sclerotinia sclerotiorum according to the
protocol described [25]. The sample concentrations in the
assay mixture were 400, 200, 100, 10 μg/ml for the MeOH
extract and 20 μg/ml for the isolated compounds. The
content of the generated ABTS●+ radical was measured at
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gallic acid equivalents by the use of a calibration curve
(Pearson’s correlation coefficient: r = 0.998) constructed
with 0, 4, 10, 14, 28, 56, 84 μM gallic acid standards rather
than Trolox [22,23]. Experiments were done in triplicate.
Hemolytic assay
Whole blood (10 ml) from a healthy man was collected
into a conical tube containing heparin as an anticoagu-
lant (blood group O was used). Authorization for the
collection of blood was obtained from the Medical and
Ethical Committee (in Yaoundé-Cameroon). The written
informed consent for participation in the study was ob-
tained from a parent of 39 years old. Erythrocytes were
harvested by centrifugation for 10 min at 1,000 × g and
room temperature and washed three times in PBS solu-
tion. The top layer (plasma) and the next, milky layer
(buffy coat with a layer of platelets on top of it) were
then carefully aspirated and discarded. The cell pellet
was resuspended in 10 ml of PBS solution and mixed by
gentle aspiration with a Pasteur pipette. This cell sus-
pension was used immediately.
For the normal human red blood cells, which are in
suspension, the cytotoxicity was evaluated as previ-
ously described [26]. MeOH extract (at concentrations
ranging from 64 to 2048 μg/ml) and compounds 2–5
(32 to 512 μg/ml), were incubated with an equal vol-
ume of 1% human red blood cells in phosphate buff-
ered saline (10 mM PBS, pH 7.4) at 37°C for 1 h.
Ampicillin and chloramphenicol were tested simultan-
eously. Non-hemolytic and 100% hemolytic controls were
the buffer alone and the buffer containing 1% Triton X-
100, respectively. Cell lysis was monitored by measuring
the release of hemoglobin at 595 nm with a spectropho-
tometer (Thermo Scientific, USA). Percent hemolysis was
calculated as follows:
A595 of sample treated with compound–A595 of sample treated with bufferð Þ½ 
A595 of sample treated with Triton  –100 –A595 of sample treated with bufferð Þ½   100
Statistical analysis
Statistical analysis was carried out using Statistical Pack-
age for Social Science (SPSS, version 12.0). The experi-
mental results were expressed as the mean ± Standard
Deviation (SD). Group comparisons were performed
using One Way ANOVA followed by Waller-Duncan




The MeOH extract of O. spinosa leaves was separated by
silica gel column chromatography to give several sub-
fractions which were further purified by open columnchromatography to afford five known compounds previ-
ously described in the literature (Figure 1). They included
kaempferol (1) [15], quercetin (2) [16], apigenin-7-O-β-D-
glucuronopyranoside (3) [17,18], quercetin 3-O-β-D-
galactopyranoside (4) [16] and quercetin 3-O-α-L-rham-
nopyranosyl (1→ 6) β-D-glucopyranoside (5) [19].Antimicrobial activity
The MeOH extract and four of its isolated compounds
(2–5) were examined in vitro against bacterial and fungal
species and the results are depicted in Table 1. Kaemp-
ferol (1), obtained in small amount, was not tested. The
MeOH extract and compounds 2, 3, 4, 5 showed select-
ive activities; their inhibitory effects being noted respect-
ively on 7/7 (100%), 7/7 (100%), 4/7 (57.14%), 7/7 (100%)
and 4/7 (57.14%) of the studied microorganisms. Klebsi-
ella pneumoniae ATCC11296 and Enterobacter aerogenes
ATCC13048 were the most sensitive bacteria while the
most sensitive fungi were Candida parapsilosis and
Cryptococcus neoformans IP 90526. The MeOH extract
showed only fungistatic activity against yeast strains
while the killing effects of many tested samples could be
expected on the sensitive strains at the MMC values not
more than twofold their corresponding MICs [27]. The
MeOH extract, compounds 2 and 4 were found to be ac-
tive against all the microbial strains. Compound 5 was
more active than 4 and the later than 2, against all the
bacterial strains. The reverse observations were noted
with the fungal strains with compound 2 more active
than 4, and compound 5 being inactive. The three com-
pounds have the same aglycon moiety. Therefore, the
sugar moieties at position 3 in 4 and 5 should be re-
sponsible for the difference in the observed activity.
The lowest MIC value for these tried compounds
(8 μg/ml) was recorded with compound 5 on K. pneu-
moniae ATCC11296. This compound displayed the
largest antibacterial activity. The antibacterial and an-
tifungal activities of the tried samples were in some
cases equal or more important than those of two ref-
erence drugs chloramphenicol (MIC = 16 – 64 μg/ml)
and nystatin (MIC = 128 – 256 μg/ml), highlighting
their good antimicrobial potency. Taking into account
the medical importance of the tested microorganisms,
this result can be considered as promising in the per-
spective of new antimicrobial drugs development. The
present study showed antimicrobial activity of flavo-
noids (phenolic compounds) and MeOH extract from
O. spinosa leaves against the microorganisms including
bacterial and fungal species. Compounds 1–5 were
previously obtained from other sources, but they are
isolated here for the first time from the genus
Oncoba. In addition, this is the first time that second-


























































Figure 1 Chemical structures of the isolated compounds from O. spinosa. 1: kaempferol; 2: quercetin; 3: apigenin-7-O-β-D-glucuronopyranoside;
4: quercetin 3-O-β-D-galactopyranoside; 5: quercetin 3-O-α-L-rhamnopyranosyl (1→ 6) β-D-glucopyranoside.
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erable interest because of a large variety of biological
activities, such as antioxidant [28], antiplasmodial [29],
cytotoxic [30], anti-inflammatory [31], antidiabetic [32]
and antimicrobial [19,33]. However, no study has been
reported on the antimicrobial activity of the com-
pounds 2–5 and MeOH extract from the leaves of O.
spinosa against these types of pathogenic strains. The
mechanism of the active compounds (2–5) is still to be
studied; nevertheless, their activity is probably due to
their ability to complex with extracellular and soluble
proteins and to complex with bacterial cell walls. More
lipophilic flavonoids may also disrupt microbial mem-
branes [34].
Antioxidant activity
Both with DPPH and TEAC methods, compound 2
(EC50 = 5.08 μg/mL; TEAC = 89.86 μg/ml) showed the
highest antioxidant activity (AOA) followed in decreasingorder by compound 5 (EC50 = 9.63 μg/ml; TEAC =
78.35 μg/ml), compound 4 (EC50 = 13.44 μg/ml; TEAC =
72.95 μg/ml), compound 3 (EC50 = 29.16 μg/ml; TEAC =
53.76 μg/ml) and MeOH extract (EC50 = 70.56 μg/ml;
TEAC = 68.32 μg/ml) (Figures 2 and 3). The free radical
scavenger activity of compound 2 is comparable to that
of vitamin C used as reference antioxidant drug (EC50 =
4.72 μg/ml), highlighting its good antioxidant potency.
In addition to the flavonoid compounds, alkaloids, tan-
nins, sterols, and anthraquinones were previously detected
in the 70% aqueous ethanol, hexane and chloroform ex-
tracts from O. spinosa [6]. Phenolic compounds such as
flavonoids are known to be potential antioxidant due to
their ability to scavenge free radicals and active oxygen
species such as singlet oxygen, superoxide anion radical
and hydroxyl radicals [35,36]. Therefore, the presence of
such compounds could be responsible for the antioxidant
activity found in the MeOH extract. To the best of our
knowledge, this is the first systematic screening for the









MIC 256 64 128 32 32 64
MBC 512 64 128 64 32 64
MBC/MIC 2 1 1 2 1 1
Escherichia coli
ATCC8739
MIC 512 128 >256 128 64 64
MBC 1024 256 nd 128 64 64
MBC/MIC 2 2 nd 1 1 1
Klebsiella pneumoniae
ATCC11296
MIC 256 64 256 32 8 16
MBC 512 64 256 64 16 16
MBC/MIC 2 1 1 2 2 1
Staphylococcus aureus MIC 1024 256 >256 128 64 64
MBC 1024 >256 nd 128 128 64
MBC/MIC 1 nd nd 1 2 1
Candida parapsilosis MIC 1024 64 64 128 >256 256
MFC >2048 64 128 256 nd 256
MFC/MIC nd 1 2 2 nd 1
Candida albicans
ATCC 9002
MIC 2048 128 >256 256 >256 128
MFC >2048 128 nd 256 nd 128
MFC/MIC nd 1 nd 1 nd 1
Cryptococcus neoformans
IP 90526
MIC 1024 64 128 128 >256 128
MFC >2048 64 128 128 nd 256
MFC/MIC nd 1 1 1 nd 2
*: nystatin for fungi and chloramphenicol for bacteria; nd: not determined; MIC: Minimum Inhibitory Concentration; MBC: Minimum Bactericidal Concentration;
MFC: Minimum Fungicidal Concentration.
Figure 2 Equivalent concentrations of test samples scavenging 50% of DPPH radical (EC50). Bars represent the mean ± SD of three independent
experiments carried out in triplicate. Letters a-e indicate significant differences between samples according to one way ANOVA and Waller
Duncan test; p < 0.05.
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Figure 3 Gallic acid equivalent antioxidant capacity (TEAC; μg/ml) of tested samples. Bars represent the mean ± SD of three independent
experiments carried out in triplicate. Letters a-e indicate significant differences between samples according to one way ANOVA and Waller
Duncan test; p < 0.05.
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from O. spinosa.Hemolytic activity
Human red blood cells provide a handy tool for toxicity
studies of compounds, because they are readily available,
their membrane properties are well known, and their
lysis is easy to monitor by measuring the release of
hemoglobin [26]. To investigate the potential use of
MeOH extract and compounds 2–5, the cellular toxicity
also has to be determined. In this study, none of the
tested samples showed hemolytic activities against hu-
man red blood cells at concentrations up to 512 μg/ml
and 2048 μg/ml for isolated compounds and MeOH ex-
tract respectively (results not shown). This finding high-
lights the fact that the observed biological efficacy is not
due to cytotoxicity.Conclusion
The phytochemical study of the MeOH extract of O. spi-
nosa leaves afforded five known flavonoids including
kaempferol (1), quercetin (2), apigenin-7-O-β-D-glucur-
onopyranoside (3), quercetin 3-O-β-D-galactopyranoside
(4) and quercetin 3-O-α-L-rhamnopyranosyl (1→ 6) β-
D-glucopyranoside (5). The MeOH extract and com-
pounds 2–5 possess significant antimicrobial and anti-
oxidant activities with no toxicity to human red blood
cells. They may be used as phytomedicines at low cost
and easily affordable by the target population with cau-
tion of clinical studies currently going on in our
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